Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03811002 |
|---|---|
| Brief Title: | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) |
| First Submitted : | January 18, 2019 |
| First Submitted that Met QC Criteria : | January 18, 2019 |
| First Posted : | January 22, 2019 |
| Last Update Submitted that Met QC Criteria : | March 22, 2023 |
| Last Update Posted : | March 23, 2023 |